Pregled bibliografske jedinice broj: 253867
Frequency of human platelet antigen genotypes in children with arterial ischemic stroke
Frequency of human platelet antigen genotypes in children with arterial ischemic stroke // Pathophysiology of Haemostasis and Thrombosis. / Varon, David (ur.).
Basel : Freiburg : Paris : London: S.Karger AG, 2006. (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 253867 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Frequency of human platelet antigen genotypes in children with arterial ischemic stroke
Autori
Coen Herak, Desiree ; Pavić, Marina ; Radić Antolić, Margareta ; Leniček Krleža, Jasna ; Miloš, Marija ; Basnec Brkić, Anica ; Dodig, Slavica ; Đuranović, Vlasta ; Zadro, Renata
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Pathophysiology of Haemostasis and Thrombosis.
/ Varon, David - Basel : Freiburg : Paris : London : S.Karger AG, 2006
ISBN
978-3-8055-8633-7
Skup
19th International Congress on Thrombosis
Mjesto i datum
Tel Aviv, Izrael, 14.05.2006. - 18.05.2006
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
human platelet antigen; polymorphism; arterial ischemic stroke
Sažetak
Arterial ischemic stroke (AIS) in children is a relatively rare disease (with incidence of 2.7 per 100, 000 children/year) not yet clearly understood and with multifactorial etiology. Besides well established risk factors for AIS, there are accumulating data indicating the importance of prothrombotic abnormalities due to defects in coagulation and fibrinolytic system, endothelial cells and platelets. Among these, the role of platelets has not been well studied. The aim of our study was to determine the frequency of human platelet antigen (HPA) genotypes in the group of children with AIS (confirmed by brain imaging), and to compare the data with those obtained for the control group. The AIS group consisted of 22 children (15 males, 7 females ; age at first onset 11 months to 16 years) whereas 26 children (20 males, 6 females ; aged from 2 to 18 years) were included in the control group. The genotypes of HPA-1, HPA-2, HPA-3 and HPA-5 were determined by sequence-specific primer polymerase chain reactions. The calculated allele frequencies were as follows: for AIS patients, HPA-1a/b 0.75/0.25, HPA-2a/b 0.86/0.14, HPA-3a/b 0.77/0.23, HPA-5a/b 0.89/0.11 ; and for control subjects HPA-1a/b 0.94/0.06, HPA-2a/b 0.92/0.08, HPA-3a/b 0.50/0.50, HPA-5a/b 0.89/0.11. No statistically significant differences in the frequencies of HPA-2 (p=0.5429) and HPA-5 (p=0.7729) between AIS patients and control subjects could be detected, while statistically significant differences were obtained for HPA-1 (p=0.0195) and HPA-3 (p=0.0118) allele frequencies. These results indicate the potential role of glycoprotein IIb/IIIa and HPA-1 and -3 polymorphisms in platelet activation, and possible involvement in the thrombotic event.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
0214212
098-0982464-3120 - Farmakogenetika u dječjoj onkologiji (Stepan Giljević, Jasminka, MZOS ) ( CroRIS)
Ustanove:
Klinika za dječje bolesti Medicinskog fakulteta,
Klinički bolnički centar Zagreb,
Zdravstveno veleučilište, Zagreb
Profili:
Anica Bašnec Brkić
(autor)
Marija Miloš
(autor)
Vlasta Đuranović
(autor)
Margareta Radić Antolic
(autor)
Slavica Dodig
(autor)
Renata Zadro
(autor)
Jasna Leniček Krleža
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE